Literature DB >> 11861047

Gender differences in the long QT syndrome: effects of beta-adrenoceptor blockade.

Chantal E Conrath1, Arthur A M Wilde, Rosalie J E Jongbloed, Mariëlle Alders, Irene M van Langen, J Peter van Tintelen, Pieter A Doevendans, Tobias Opthof.   

Abstract

BACKGROUND: Gender differences have been reported in patients with the congenital long QT syndrome (LQTS). We analyzed whether electrocardiographic differences existed in females, males, girls and boys in response to beta-adrenoceptor blockade.
METHODS: 12-lead ECGs before and during beta-adrenoceptor blockade were collected in 87 genotyped LQTS patients (48 women, 14 men, 12 girls and 13 boys). Up to three QTc intervals were determined in each lead of the ECG. V4 was used for QT/QTc analysis. Difference between longest and shortest QT interval was taken as a measure for dispersion of QT intervals.
RESULTS: (1) Adult males had the greatest shortening of the QTc interval upon treatment with beta-adrenoceptor blockade. During treatment, adult males with LQTS(1) (mutation in the KCNQ1 gene, affecting I(Ks) current) were found to have shorter QTc intervals than adult females; this difference did not exist in LQTS(2) patients (mutation in the HERG gene, affecting I(Kr) current). (2) Female LQTS(2) patients had a 50% larger dispersion than female LQTS(1) patients both before and during treatment. (3) Adult male LQTS(1) patients constitute the only patient group with a marked decrease in QTc intervals and dispersion associated with a 100% efficacy of treatment in response to beta-adrenoceptor blockade.
CONCLUSIONS: These findings indicate that, in addition to underlying differences in repolarization between men and women, cardiac electrophysiological responses to beta-adrenoceptor blockade can be modulated by gender-related factors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861047     DOI: 10.1016/s0008-6363(01)00477-1

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  8 in total

Review 1.  The risk of cardiac events and genotype-based management of LQTS patients.

Authors:  Grazyna Markiewicz-Łoskot; Ewa Moric-Janiszewska; Urszula Mazurek
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-01       Impact factor: 1.468

Review 2.  How do sex hormones modify arrhythmogenesis in long QT syndrome? Sex hormone effects on arrhythmogenic substrate and triggered activity.

Authors:  Katja E Odening; Gideon Koren
Journal:  Heart Rhythm       Date:  2014-06-19       Impact factor: 6.343

3.  Surgical left cardiac sympathetic denervation for long QT syndrome: effects on QT interval and heart rate.

Authors:  Cuilan Li; Dayi Hu; Lihua Shang; Shan Ma; Wenling Liu; Yuntian Li; Zhimin Ma; Chuzhong Tang; Yunqing Mei; Lexin Wang
Journal:  Heart Vessels       Date:  2005-07       Impact factor: 2.037

4.  Long QT syndrome: A therapeutic challenge.

Authors:  Maully Shah; Christopher Carter
Journal:  Ann Pediatr Cardiol       Date:  2008-01

5.  Predictive factors for an effective beta-blocker therapy in Chinese patients with congenital long QT syndrome: A multivariate regression analysis.

Authors:  Lexin Wang; Tongguo Wu
Journal:  Exp Clin Cardiol       Date:  2004

Review 6.  Long QT syndrome. Why does sex matter?

Authors:  S Kääb; A Pfeufer; M Hinterseer; M Näbauer; E Schulze-Bahr
Journal:  Z Kardiol       Date:  2004-09

7.  Asymmetry of parental origin in long QT syndrome: preferential maternal transmission of KCNQ1 variants linked to channel dysfunction.

Authors:  Hideki Itoh; Myriam Berthet; Véronique Fressart; Isabelle Denjoy; Svetlana Maugenre; Didier Klug; Yuka Mizusawa; Takeru Makiyama; Nynke Hofman; Birgit Stallmeyer; Sven Zumhagen; Wataru Shimizu; Arthur A M Wilde; Eric Schulze-Bahr; Minoru Horie; Sophie Tezenas du Montcel; Pascale Guicheney
Journal:  Eur J Hum Genet       Date:  2015-12-16       Impact factor: 4.246

Review 8.  A framework for developing sex-specific engineered heart models.

Authors:  Roberta Lock; Hadel Al Asafen; Sharon Fleischer; Manuel Tamargo; Yimu Zhao; Milica Radisic; Gordana Vunjak-Novakovic
Journal:  Nat Rev Mater       Date:  2021-10-20       Impact factor: 76.679

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.